Compare Toronto-Dominion Bank (TD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toronto-Dominion Bank vs State Street SPDR S&P Biotech ETF — how do they compare? Toronto-Dominion Bank trades at $120.5 (market cap $197.03B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Toronto-Dominion Bank pays a 2.62% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| TD | XBI | |
|---|---|---|
Market Cap | $197.03B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $124.80 | $164.28 |
52-Week Low | $72.55 | $85.16 |
Dividend Yield | 2.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
